中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2014年
11期
1653-1655
,共3页
肺栓塞%危险因素
肺栓塞%危險因素
폐전새%위험인소
Pulmonary thromboembolism%Risk factors
目的 探讨肺血栓栓塞患者的危险因素及不同治疗方法对患者预后的影响.方法 收集182例肺血栓栓塞患者的临床资料,对危险因素进行分析;对单纯药物治疗组(抗凝或抗凝+溶栓)、药物联合介入治疗组(药物治疗联合腔静脉滤器植入或/和导管碎栓术)的患者预后进行对比.结果 182例患者中,老年人及吸烟者患病率明显升高,下肢深静脉血栓、心血管疾病、肿瘤、血液系统疾病、创伤及外科手术、慢性肺部疾病、骨折及骨科手术为主要危险因素.单纯药物治疗与药物联合介入治疗组的有效率、病死率差异无统计学意义(x2 =0.145,P＞0.05).结论 肺栓塞的发病率与危险因素密切相关,肿瘤是引起肺栓塞的第三大危险因素;及时予以抗血栓药物治疗对肺血栓栓塞预后意义重大,与抗血栓联合介入治疗比较疗效相当.
目的 探討肺血栓栓塞患者的危險因素及不同治療方法對患者預後的影響.方法 收集182例肺血栓栓塞患者的臨床資料,對危險因素進行分析;對單純藥物治療組(抗凝或抗凝+溶栓)、藥物聯閤介入治療組(藥物治療聯閤腔靜脈濾器植入或/和導管碎栓術)的患者預後進行對比.結果 182例患者中,老年人及吸煙者患病率明顯升高,下肢深靜脈血栓、心血管疾病、腫瘤、血液繫統疾病、創傷及外科手術、慢性肺部疾病、骨摺及骨科手術為主要危險因素.單純藥物治療與藥物聯閤介入治療組的有效率、病死率差異無統計學意義(x2 =0.145,P＞0.05).結論 肺栓塞的髮病率與危險因素密切相關,腫瘤是引起肺栓塞的第三大危險因素;及時予以抗血栓藥物治療對肺血栓栓塞預後意義重大,與抗血栓聯閤介入治療比較療效相噹.
목적 탐토폐혈전전새환자적위험인소급불동치료방법대환자예후적영향.방법 수집182례폐혈전전새환자적림상자료,대위험인소진행분석;대단순약물치료조(항응혹항응+용전)、약물연합개입치료조(약물치료연합강정맥려기식입혹/화도관쇄전술)적환자예후진행대비.결과 182례환자중,노년인급흡연자환병솔명현승고,하지심정맥혈전、심혈관질병、종류、혈액계통질병、창상급외과수술、만성폐부질병、골절급골과수술위주요위험인소.단순약물치료여약물연합개입치료조적유효솔、병사솔차이무통계학의의(x2 =0.145,P＞0.05).결론 폐전새적발병솔여위험인소밀절상관,종류시인기폐전새적제삼대위험인소;급시여이항혈전약물치료대폐혈전전새예후의의중대,여항혈전연합개입치료비교료효상당.
Objective To study the risk factors of pulmonary embolism and comparison of the effect of different therapy.Methods Risk factors of 182 patients with pulmonary embolism were analyzed retrospectively.The patients were randomly divided into simple drug group and drug joint intervention group.Simple drug group was given heparin and warfarin,or jiont urokinase fibrinolytic therapy.The drug joint intervention group was given the same drug therapy joint vena cava filter implantation and/or catheter broken bolt therapy.After different treatment,the clinical prognosis was compared between the two groups.Results Of 182 patients with pulmonary embolism,the elderly and smoking prevalence rate increased significantly,deep vein thrombosis,cardiovascular disease,cancer,blood system diseases,trauma and surgery,chronic lung disease,fracture and orthopaedic surgery were the main risk factors.The effective rate and mortality between the pure drug therapy group and drug joint intervention group had no significant differences(x2 =0.145,P ＞ 0.05).Conclusion The incidence of pulmonary embolism is closely related to the risk factors.Cancer is one of the important diseases caused by pulmonary embolism.In a timely manner to give the antithrombotic drug treatment has great significance to the prognosis of pulmonary thromboembolism,there was no significant difference compared with the antithrombotic joint intervention.
